INTRODUCTION
The incidence of congenital diaphragmatic hernia (CDH) is 0.3 per 1000 live births. 1 Despite sophisticated technological and surgical advances, the mortality of all patients born with this abnormality is 40% to 60%. 2 Although some infants die before treatment can be instituted, most patients are offered maximal therapy involving medical as well as surgical intervention. The treatment course can be lengthy. About half of these infants and their families will endure a protracted period of maximal medical and invasive therapies, with extensive utilization of healthcare resources, and nonetheless succumb to their condition. 3 -9 This may be due to pulmonary hypoplasia or other developmental pathology that occurs in utero as a result of the abdominal contents being misplaced in the thorax during critical periods of embryogenesis. Severe cardiopulmonary developmental abnormalities are not amenable to medical or surgical treatment, but efforts to prospectively identify those patients who will not benefit from therapy have heretofore been unsuccessful. 6 -8,10 -14 We sought to identify a statistical model using echocardiographic indices that could be used as a marker to predict nonsurvivors from survivors in preoperative patients with CDH.
METHODS
Eight cases of CDH were treated at the Medical University of South Carolina (MUSC) during the period December 1997 to May 2000. The mortality rate in this series was 38%. All patients underwent echocardiographic study before surgical repair utilizing the Interspec Apogee CÂ200 (Interspec, Ambler, PA) and HewlettPackard Ultrasound systems (Palo Alto, CA). This automated technology used to calculate LVMASS employs Model 4 of the area-length method of Wyatt et al. 15 The specific dimensions included in the automated calculation include the left ventricular epicardial short axis area at the level of the papillary muscle tips at end diastole, left ventricular endocardial short axis cavity area at the level of the papillary muscle tips at end diastole, and left ventricle long-axis length at end diastole (through apical fouror two-chamber views). 16 Of the seven models proposed by Wyatt et al., 15 Model 4, with its assumption of half-cylinder, halfellipsoid shape, provides ''. . . the closest estimation of LV mass, as judged by the scatter of values around the identity line'' (r 2 =0.938). 15 This model proved to be accurate and applicable in ''hearts with extensive regional asymmetry'' 15 and was greatly simplified and, therefore, more preferable to employing Simpson's rule in a clinical setting. 15 Fractional shortening (FS) was determined by measuring the left ventricular internal diameter in
OBJECTIVE:
To develop a predictive model using echocardiographic indices to identify nonsurvivors from survivors in preoperative patients with congenital diaphragmatic hernia ( CDH ).
STUDY DESIGN:
Eight cases of CDH, with a mortality rate of 38%, underwent echocardiographic study before surgical repair. Left ventricular mass ( LVMASS ) using the area -length method of Wyatt et al. and fractional shortening ( FS ) by M -mode measurements were determined.
RESULTS:
We identified a nonlinear nonoverlapping distribution that predicted nonsurvivors from survivors, p = 0. 
CONCLUSION:
The mathematical quantity ( LVMASSÂFS ) 1 / 2 calculated from echocar-
diastole and systole from the parasternal short axis view (LVDÀLVS/LVD). An example of these procedures is shown in Figure 1 . In six cases, these measurements were taken retrospectively from stored echocardiographic images, and prospectively during initial echocardiographic evaluation in the other two cases. All measurements were performed by the same echocardiographic technician (D.F.). A variety of common mathematical transformations of these quantities, including inversions, exponents, multiples and logs (e.g., 1/FS, LVMassÂFS=I, I
2 , log I, I 1 / 2 , 1/FS 2 , FS 1 / 2 ) were analyzed using Statistica (StatSoft Tulsa, OK) and SAS (SAS Software, SAS Institute, Cary, NC) automated statistical software packages. Data transformation allows application of linear regression methodology to data sets that may demonstrate primary nonlinear relationships. Multiple linear regression (MLR) allows simultaneous assessment of the correlation of more than one variable with a particular outcome. Different combinations of transformed and raw variables obtained from the first six cases were assessed for correlation with outcome (e.g., death) using MLR techniques. After development of the model, it was prospectively applied to the last two cases. The principal investigator was blinded to the all eight patients' outcomes until after the model had been applied. This protocol was reviewed by the Institutional Review Board for Human Subjects Research at MUSC. Because the protocol involved utilization of data that were already collected in the course of standard medical care, it was granted ''exempt'' status from the requirement for informed patient consent.
RESULTS
Characteristics of the eight patients studied are displayed in Table 1 . Statistical comparison of the group of survivors with Figure 1 . Echocardiographic calculation of LVMASS using the arealength method of Wyatt et al. 15 A, Measurement of LV volume based on Simpson's biplanes. B and C, Measurements of internal and external LV dimensions. Software included in the Hewlett -Packard ultrasound system utilizes these measurements to automatically perform the calculation. Table 2 , with (LVMASSÂFS) 1 / 2 demonstrating a correlation coefficient r 2 =0.60, p=0.07. Prospective application of this model to two more cases resulted in an increase in statistical significance of its ability to differentiate nonsurvivors from survivors to p=0.04, and a decrease in its coefficient of correlation, r 2 =0.55. Table 1 displays the mean values of this quantity for each group. Application of Student's t-test to these values suggests they represent two distinct populations. Values of this quantity for all eight patients studied are displayed in Table 3 .
DISCUSSION
We have identified a nonoverlapping distribution involving echocardiographic measurement of LVMASS and shortening fraction that predicted nonsurvivors from survivors in patients with CDH with 100% sensitivity, 100% specificity, and 100% positive and negative predictive values. In 1998, Baumgart et al. 14 reported the presence of left ventricular hypoplasia in nonsurvivors of CDH. It was this report that prompted us to further examine the utility of this measure, and ultimately develop the model we are reporting here.
There is a pathophysiologic basis by which LVMASS may correlate with nonsurvival in CDH. The majority of diaphragmatic hernias (85%) result from extrusion of the abdominal contents through the foramen of Bochdalek on the left side of the diaphragm at approximately the 10th week of gestation. 17 The presence of the abdominal organs in the left hemithorax displaces the fetal heart to the right and interferes with normal lung development. 17 Thus, the infant is born with pulmonary hypoplasia that persists after the abdominal organs have been returned to their anatomic position and the defect is closed. 2 Reduction in lung volume and abnormal pulmonary vascular architecture in the most severely affected infants results in persistent pulmonary hypertension, and greatly worsens the chance for survival. 6,10,18 -20 It is the degree of abnormal pulmonary development that may ultimately determine an infant's chance of survival. Although this parameter cannot be directly measured or observed in vivo, heart size, however, can be quantified. Inductive reasoning suggests that, if the developmental insult is great enough to compromise cardiac development, it may also have affected pulmonary development, perhaps to some mathematically correlated degree.
Others have attempted to identify prognostic factors for survival in patients with CDH, without success. 8 Albanese et al. 11 reported that postnatal survival was significantly less in infants in whom the liver was identified on prenatal ultrasound to be present in the left hemithorax (43%), compared with those in whom it was not (93%). Thibeault and Haney, 6 in 1998, examined postmortem findings of lung volumes in 18 patients with CDH, and identified a critical value of >45% of the value predicted for age-matched controls necessary for survival in ECMO-treated infants. Although useful, this information cannot be used prospectively to identify nonsurvival. In 1997, Lipschutz et al. 12 proposed the use of an index of severity of CDH, the lung-to-head ratio (LHR), obtained ultrasonographically at 24 to 26 weeks' gestation. In a series of 15 patients analyzed prospectively, LHR <1.0 accurately predicted nonsurvival in 3 patients and LHR >1.4 correctly predicted survival in 4 patients. These distributions, however, were overlapping, and, for the majority of patients, 1.0<LHR<1.4. Survival of patients in this range was 38%. Keshen et al. 7 used logistic regression to formulate an equation predictive of survival. This equation, which employs Apgar score at 5 minutes, birth weight, ventilatory index, and best preoperative PaCO 2 in a cumbersome format, yielded a sensitivity of 94% and a specificity of 82%. Other investigators have proposed using blood gas values, 19 lung/thorax transverse ratios, 21 functional residual capacity, 10 and best preoperative postductal PaO 2 . 13, 22 None of these parameters accurately predict which patients will survive if treated for CDH. 8 Published reports from multiple ECMO centers comparing their mortality rates pre-and post-ECMO demonstrate that a significant subgroup of patients -and their families -are subjected to protracted periods of maximal medical, surgical, and invasive therapies, with the attendant risks of complications inherent to these therapies, and still do not survive to be discharged from the hospital. One recent series of 11 infants born 3 The emotional, as well as financial cost of these ultimately futile treatments is immense. Although it is impossible to quantify the cost of pain and suffering in human terms, Metkus et al. 23 in 1995 reported the economic cost of CDH per year in the United States to be more than $230 million. The cost per survivor was $98,000 for those not requiring ECMO compared with $365,000 in the ECMO group. Keshen et al. 7 reported the mean hospital cost in six nonsurvivors with CDH treated with ECMO to be $277,264.75±$59,500.71. Ability to predict nonsurvival in these patients may be of great clinical value when counseling families; despite sophisticated medical and surgical advancements, including the advent of ECMO, high-frequency ventilation and inhaled nitric oxide, the mortality rate remains basically unchanged at greater than 50%. 1, 21, 24, 25 This model is not without its limitations. Echocardiographic measurement of the asymmetrical left ventricle, especially in patients with persistent pulmonary hypertension, can be inaccurate and invalid. Although Wyatt's model includes compensation for this, it may be difficult to develop a mathematical model that considers inherent biologic and pathophysiologic variability. Nonetheless, to date both retrospectively and prospectively, this model has demonstrated 100% predictability. Although it is unlikely that this perfection will persist with broader application, the current findings cannot be dismissed. The quantity utilized by this model, although grounded in pathogenesis, has no inherent physiologic significance, which may make it intuitively difficult for clinicians to embrace. However, its potential ability to contribute a valuable clinical service may help its users to surmount this objection. The measurements reported here were all performed by the same skilled technician. The ability of a wide range of echocardiographic operators to achieve similar results remains untested. Although this would clearly reduce the widespread applicability of this tool, the results reported here are so compelling as to deserve a broader examination.
CONCLUSION
The inability to predict with sufficient accuracy which babies born with CDH cannot survive has resulted in all babies being offered maximal medical and surgical therapy, despite the recognition that such treatment will be futile in a significant proportion of them. We have identified a statistical quantity that has demonstrated, to date, infallible ability to immediately identify those infants in whom the embryologic impact of their defect precludes survival despite maximal medical intervention. Such a tool may facilitate decision making early in the infant's course, conserve limited health care resources, and perhaps spare the infant and his/her family enormous pain and suffering.
